I had a flu jab in a Pharmacy in Melbourne today and noticed packs of Fleurstat on the shelves behind. "How well does that product sell?," said I, saying I'm a shareholder.
"It's a great product," replied the pharmacist, "but sales are very low. It's just not marketed effectively to doctors and everybody else." Then I told them about Viraleze. They had never heard of it, and couldn't believe that a product with over 99% effectiveness against the COVID-19 virus could fail to get approval, let alone sell millions of dispensers world wide in a 100-year pandemic.
"Well, that's Starpharma," I said. "Great science, no understanding of commercial realities. And little interest in shareholders."
I had a flu jab in a Pharmacy in Melbourne today and noticed...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.002(2.02%) |
Mkt cap ! $39.96M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.6¢ | $48.56K | 493.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 192364 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
9.8¢ |
Change
-0.002 ( 2.50 %) |
||||
| Open | High | Low | Volume | ||
| 9.9¢ | 10.0¢ | 9.6¢ | 118602 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| SPL (ASX) Chart |